These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10403441)

  • 21. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
    Kubota N; Kado S; Kano M; Masuoka N; Nagata Y; Kobayashi T; Miyazaki K; Ishikawa F
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty liver Shionogi-ob/ob mouse: A new candidate for a non-alcoholic steatohepatitis model.
    Sugihara T; Koda M; Kishina M; Kato J; Tokunaga S; Matono T; Ueki M; Murawaki Y
    Hepatol Res; 2013 May; 43(5):547-56. PubMed ID: 23057725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial Effects of Red Yeast Rice on High-Fat Diet-Induced Obesity, Hyperlipidemia, and Fatty Liver in Mice.
    Lee HS; Lee YJ; Chung YH; Nam Y; Kim ST; Park ES; Hong SM; Yang YK; Kim HC; Jeong JH
    J Med Food; 2015 Oct; 18(10):1095-102. PubMed ID: 26133037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of adiponectin transgenic expression in liver of nonalcoholic steatohepatitis model mice.
    Nakayama H; Otabe S; Yuan X; Ueno T; Hirota N; Fukutani T; Wada N; Hashinaga T; Yamada K
    Metabolism; 2009 Jul; 58(7):901-8. PubMed ID: 19394977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical-pathological conference series from the Medical University of Graz : case no. 131: elevated transaminases in a 30-year-old male.
    Putz-Bankuti C; Datz C; März W; Lackner C; Stauber RE; Trauner M; Toplak H; Stojakovic T; Krejs GJ
    Wien Klin Wochenschr; 2006 Dec; 118(23-24):769-75. PubMed ID: 17186174
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypolipidemic and body fat-lowering effects of Fatclean in rats fed a high-fat diet.
    Woo MN; Bok SH; Choi MS
    Food Chem Toxicol; 2009 Aug; 47(8):2076-82. PubMed ID: 19500640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
    Keshishian A; Zahriya K; Willes EB
    Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic fatty liver disease is associated with specific changes in blood-borne markers.
    Sharma S; Barrett F; Adamson J; Todd A; Megson IL; Zentler-Munro PL; MacRury SM
    Diabetes Metab Res Rev; 2012 May; 28(4):343-8. PubMed ID: 22576780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a new sustained-release microsphere formulation of exenatide, DA-3091, on obese and non-alcoholic fatty liver disease mice.
    Son JP; Son MK; Jun SW; Kwak HH; Kang SH; Kang JS; Park YI
    Pharmazie; 2013 Jan; 68(1):58-62. PubMed ID: 23444782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
    Yamazaki Y; Kakizaki S; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
    J Gastroenterol Hepatol; 2008 Feb; 23(2):276-82. PubMed ID: 17868334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease.
    Yilmaz Y; Ozturk O; Alahdab YO; Senates E; Colak Y; Doganay HL; Coskunpinar E; Oltulu YM; Eren F; Atug O; Tuncer I; Imeryuz N
    Dig Liver Dis; 2013 Jan; 45(1):58-62. PubMed ID: 22995553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astaxanthin lowers plasma TAG concentrations and increases hepatic antioxidant gene expression in diet-induced obesity mice.
    Yang Y; Pham TX; Wegner CJ; Kim B; Ku CS; Park YK; Lee JY
    Br J Nutr; 2014 Dec; 112(11):1797-804. PubMed ID: 25328157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
    Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
    J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?
    Afdhal NH
    JAMA; 2012 Aug; 308(6):608-16. PubMed ID: 22760235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P; Barkin JS
    Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.
    Sonmez A; Nikolic D; Dogru T; Ercin CN; Genc H; Cesur M; Tapan S; Karslioğlu Y; Montalto G; Banach M; Toth PP; Bagci S; Rizzo M
    J Clin Lipidol; 2015; 9(4):576-82. PubMed ID: 26228676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal granulocytosis is a postpartum event which is seen in the liver as well as in the blood.
    Kawamura T; Toyabe S; Moroda T; Iiai T; Takahashi-Iwanaga H; Fukada M; Watanabe H; Sekikawa H; Seki S; Abo T
    Hepatology; 1997 Dec; 26(6):1567-72. PubMed ID: 9397999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.